| Report ID | 282838 |
| Drug Identification Number | 02538725 |
| Brand name | XCOPRI |
| Common or Proper name | cenobamate |
| Company Name | KNIGHT THERAPEUTICS INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | CENOBAMATE |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 TABS |
| ATC code | N03AX |
| ATC description | |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2026-04-09 |
| Actual start date | 2026-04-09 |
| Estimated end date | 2026-04-24 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-04-14 |
| Company comments | Increased demand and delay in shipment of the drug product. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 ALEXIS-NIHON BLVD., SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-04-14 | French | Compare |
| v1 | 2026-04-14 | English | Compare |
Showing 1 to 2 of 2